Search bioRxiv⌕ Search

Biology subjects

Mizukoshi, C.

Publications and source records attributed to Mizukoshi, C..

4 recordsLinked to original sources

CloneVI: A deep generative model for deciphering the relationships between cell state and mitochondrial genotype

Cellular diversity arises from both genetic lineages and non-genetic regulation of cell states, and knowing which cell states are tied to lineages is central to understanding how clones shape disease. Single-cell multi-omics technologies measure mitochondrial DNA mutations together with gene expression or chromatin accessibility in the same cells, but clones are usually inferred from mutations alone, making such clones difficult to identify. We developed CloneVI, a deep generative model that infers clonal structure from a latent cell state derived from gene expression or chromatin accessibility. It estimates the clonal probability of each cell from this cell state, together with the allele frequency of each clone by reconstructing the observed mutation counts. In simulated data, CloneVI recovered the ground-truth clonal structure in both single-clone and mixed-clone cell populations. In clonal hematopoiesis single-cell RNA-seq data with enriched mitochondrial transcripts, the inferred clones were associated with specific mitochondrial DNA mutations, and some of them showed high expression of a T-cell receptor variable-region gene. In chronic lymphocytic leukemia mitochondrial single-cell ATAC-seq data, CloneVI separated populations with different heteroplasmy levels and identified increased PAX9 accessibility. In a multi-donor ovarian tumor cohort, CloneVI captured mutant-cell populations enriched in particular cell states, and a differential test weighted by the clonal probability revealed the transcription factor activity of the cell state in which the mutant cells concentrated. CloneVI thus identifies populations defined by mitochondrial DNA mutations and associated with cell states in single-cell RNA-seq and ATAC-seq data. CloneVI is available at https://github.com/TaichiHIBI/cloneVI.

bioinformatics↗

scTREND: An annotation-free single-cell time-resolved and condition-dependent hazard model

Prognosis in cancer and other complex diseases is shaped by heterogeneous cell states and clinical or genetic contexts whose effects change over time. Yet most survival analyses assume predefined cell types and time-invariant covariates, and cohorts pairing single-cell transcriptomes with outcomes are limited, obscuring within-type heterogeneity, time-varying risk, and condition-specific effects. We developed scTREND, an annotation-free, time-resolved, condition-dependent hazard model that learns variational single-cell embeddings, deconvolves bulk or spatial samples without labels, and fits a conditional piecewise-constant hazard model to estimate cell-level hazard coefficients across discrete time bins and conditions. scTREND enables cell-level risk attribution without prior cell-type annotations, dynamic risk modeling over time, and mutation- or treatment-specific risk assessment. In simulations, scTREND recovered ground-truth temporal and condition-specific coefficients with strong concordance and improved prediction over an existing method. In melanoma, scTREND identified subpopulations with risk amplified in BRAF-mutant tumors; in COVID-19, cytotoxic T-cell subpopulations with early-to-late risk reversal and pathways associated with prognosis under remdesivir; and in spatial transcriptomics of clear cell renal carcinoma, spatial regions whose prognostic relevance shifts over time. Across diseases and modalities (bulk RNA-seq and spatial transcriptomics), scTREND provides a time-resolved, condition-aware link between single-cell states and clinical outcomes and is implemented in Python (GitHub:https://github.com/R301Carbine/scTREND).

bioinformatics↗

scSurv: a deep generative model for single-cell survival analysis

Single-cell omics analysis has unveiled the heterogeneity of various cell types within tumors. However, no methodology currently reveals how this heterogeneity influences cancer patient survival at single-cell resolution. Here, we introduce scSurv, combining a Cox proportional hazards model with a deep generative model of single-cell transcriptome, to estimate individual cellular contributions to clinical outcomes. The accuracy of scSurv was validated using both simulated and real datasets. This method identifies cells associated with favorable or adverse prognoses and extracts genes correlated with their contribution levels. In melanoma, scSurv reproduces known prognostic macrophage classifications and facilitates hazard mapping through spatial transcriptomics in renal cell carcinoma. We also identified genes consistently associated with prognosis across multiple cancers and demonstrated the applicability of this method to infectious diseases. scSurv is a novel framework for quantifying the heterogeneity of individual cellular effects on clinical outcomes.

bioinformatics↗

A deep generative model for estimating single-cell RNA splicing and degradation rates

AO_SCPLOWBSTRACTC_SCPLOWMessenger RNA splicing and degradation are critical for gene expression regulation, the abnormality of which leads to diseases. Previous methods for estimating kinetic rates have limitations, assuming uniform rates across cells. We introduce DeepKINET, a deep generative model that estimates splicing and degradation rates at single-cell resolution from scRNA-seq data. DeepKINET outperformed existing methods on simulated and metabolic labeling datasets. Applied to forebrain and breast cancer data, it identified RNA-binding proteins responsible for kinetic rate diversity. DeepKINET also analyzed the effects of splicing factor mutations on target genes in erythroid lineage cells. DeepKINET effectively reveals cellular heterogeneity in post-transcriptional regulation.

bioinformatics↗